Xenetic Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Xenetic Biosciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 49% to $2,539,986. The net income raised on -$4,134,578 and profit margin reached -163%. Total operating expenses were $7,055,701.
Profit Margin
| 2014 | 0 | -14.30M | |
|---|---|---|---|
| 2015 | 0 | -12.50M | |
| 2016 | 3M | -54.20M | -1806.87% |
| 2017 | 7.58M | -3.59M | -47.4% |
| 2018 | 0 | -7.30M | |
| 2019 | 17.06K | -15.94M | -93460.18% |
| 2020 | 436.94K | -10.89M | -2493.11% |
| 2021 | 1.16M | -5.54M | -477.71% |
| 2022 | 1.70M | -6.38M | -374.17% |
| 2023 | 2.53M | -4.13M | -162.78% |
XBIOW Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 2.53M | 1.70M | 1.16M | 436.94K | 17.06K | 0 | 7.58M | 3M | 0 | 0 |
Cost of revenue | 0 | 27.04K | 35.48K | 0 | 0 | 0 | 156.11K | 0 | 56.11K | 0 |
Gross profit | 2.53M | 1.67M | 1.12M | 436.94K | 17.06K | 0 | 7.42M | 3M | -56.11K | 0 |
Operating exp. | ||||||||||
Research and development | 3.49M | 4.77M | 3.16M | 1.73M | 4.88M | 2.88M | 4.06M | 43.73M | 3.43M | 6.32M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 7.05M | 8.42M | 6.90M | 5.13M | 9.62M | 7.27M | 10.99M | 50.43M | 9.82M | 12.92M |
Operating income | -4.51M | -6.71M | -5.74M | 4.54M | -12.88M | -7.27M | -3.56M | -47.43M | -9.82M | -12.92M |
Other income (expenses), net | 381.13K | 165.55K | 101.58K | 125.67K | 111.80K | -24.64K | -26.37K | -6.04M | -2.68M | -1.38M |
Income before tax | -4.13M | -6.55M | -5.64M | -13.81M | -12.77M | -7.30M | -3.59M | -54.20M | -12.50M | -14.30M |
Income tax expense | 0 | -165.55K | -100.46K | -2.91M | 3.17M | 24.13K | 26.37K | 6.04M | 2.42M | 1.39M |
Net income | -4.13M | -6.38M | -5.54M | -10.89M | -15.94M | -7.30M | -3.59M | -54.20M | -12.50M | -14.30M |
Earnings per share | ||||||||||
Basic EPS | -2.71 | -4.49 | -5.39 | -17.04 | -55.92 | -96.58 | -49.78 | -875.41 | -355.34 | -416.91 |
Diluted EPS | -2.71 | -4.49 | -5.39 | -17.04 | -55.92 | -96.57 | -49.78 | -875.41 | -355.34 | -416.91 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |